EDGAR Filing Documents for 0001367920-18-000013

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001367920-18-000013

Filing Date

2018-03-01

Accepted

2018-03-01 07:38:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2018s-3filing.htm	S-3	417345
2	EXHIBIT 4.1	exhibit41-formofseniorinde.htm	EX-4.1	480292
3	EXHIBIT 4.2	exhibit42-formofsubordinat.htm	EX-4.2	503468
4	EXHIBIT 4.3	exhibit43-formofseniornote.htm	EX-4.3	54088
5	EXHIBIT 4.4	exhibit44-formofsubordinat.htm	EX-4.4	54442
6	EXHIBIT 5.1	exhibit51-goodwinconsent.htm	EX-5.1	20534
7	EXHIBIT 12	exhibit12-computationofrat.htm	EX-12	53473
8	EXHIBIT 23.1	exhibit231-consentofey.htm	EX-23.1	2993
9	GOODWIN LOGO	goodwinimage.jpg	GRAPHIC	32963
	Complete submission text file	0001367920-18-000013.txt		1633214

Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421

Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045

CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-223334 | Film No.: 18654726
SIC: 2834 Pharmaceutical Preparations